Direct and indirect effects of the COVID-19 pandemic on mortality in Switzerland: A population-based study

Introduction

The COVID-19 pandemic has affected mortality globally through direct and indirect effects. Infection with SARS-CoV-2 directly causes death in a small proportion of infected people, with variations in the infection-fatality ratio (IFR) depending on age (1), socio-economic position (2), vaccination status (3), intensive care unit capacity (4) and several other characteristics of individuals or communities. Combined with the high transmissibility of SARS-CoV-2, this resulted in more than 6 million laboratory-confirmed deaths globally as of July 12, 2022 (5). The pandemic has also caused major disruptions in many aspects of social and economic life and may thus have indirectly increased or reduced mortality. Non-pharmaceutical interventions (NPIs) may lead to delays or avoidance of medical care (6, 7), increases in substance use and suicidal ideation (8-10), or increases in interpersonal violence (11). Conversely, stay-at-home orders have led to reductions in mobility and traffic (12) and air pollution levels (13). Border closures and cutbacks in social contacts and activities have restricted the circulation of other infectious diseases (14). The respective importance of the pandemic’s positive and negative indirect effects on mortality and the net impact remains unknown.

The overall impact of the COVID-19 pandemic on mortality at the population level, both directly and indirectly, is of great concern to public health but is difficult to quantify. Laboratory-confirmed deaths (i.e., deceased people with a recent positive SARS-CoV-2 test) may underestimate mortality as some deaths will remain unascertained, for example, due to testing policies, shortages, underreporting, or overwhelmed health systems (15). Laboratory-confirmed deaths ignore indirect effects on mortality. The main alternative relies on excess mortality estimated from all-cause mortality data, using counterfactual reasoning (16). The observed number of deaths is compared to what would have been expected had the pandemic not occurred, based on mortality data from previous years and considering demographic changes and covariates associated with mortality patterns. The approach has the advantage of covering both the pandemic’s direct and indirect effects, although phenomena like mortality displacement can limit the interpretability of results (17-19). Also, estimations of excess mortality depend on model assumptions and methodological choices, such as age-specific population trends (20). Detailed analyses of causes of death as listed in death certificates can also be used (generally with considerable delay) but suffer from significant limitations, especially regarding ascertaining infectious diseases (21).There have been many attempts to estimate excess mortality associated with the COVID-19 pandemic (22-32). Comparisons of excess mortality with laboratory-confirmed deaths have confirmed that the overall impact of the pandemic on mortality is generally much greater than what is indicated by laboratory-confirmed deaths alone (23, 28, 30). Still, a common limitation of these studies is the inability to distinguish between the direct and indirect effects of the pandemic on mortality. This study attempts to overcome this limitation by jointly studying laboratory-confirmed COVID-19-related deaths and excess mortality. We computed the expected number of all-cause deaths by week, age group, and location in Switzerland between February 2020 and April 2022, accounting for the effect of temperature, national holidays, and population changes using a validated statistical approach (33). We then developed a method to decompose all-cause mortality into deaths directly attributable to SARS-CoV-2 infection and deaths indirectly attributable to the pandemic. We could thus examine the completeness of ascertainment of COVID-19-related deaths and the indirect effects of the pandemic on all-cause mortality in Switzerland.

Methods

Results

We observed a total of 156,193 deaths from all causes in Switzerland from February 24, 2020, to April 3, 2022, compared to an expected 142,408 [95% Credible Interval: 138,044-149,125] had the pandemic not occurred. This translates into 13,785 [7,068-18,149] excess all-cause deaths over the pandemic period, a relative increase of 9.7% [4.7-13.1]. There were three periods of substantial relative excess mortality: 7.3% [3.8-10.8] during phase 1, 33.9% [26.4-41.4] during phase 3 and 15.9% [8.3-22.8] during phase 6 (Table 1). There was some evidence suggesting mortality displacement during phase 4, with a relative excess mortality of -4.3% [-9.9-0.2]. The age groups affected most by excess mortality were those over 70 years of age (Figure 1A and B). A total of 13,130 laboratory-confirmed COVID-19-related deaths were reported during the study period. Weekly counts of laboratory-confirmed deaths generally aligned with estimates of excess all-cause mortality in Switzerland (Figure 2), with a correlation coefficient of 0.89 [0.85-0.92]. The estimate of β_l was 1.38 [1.22-1.54], suggesting that there were, on average, 38% [22-54] more deaths directly attributable to COVID-19 than laboratory-confirmed deaths during the period or that the ascertainment proportion was 72% [65-82] (Table 1). Given the 13,130 laboratory-confirmed deaths over the period, this implies that the total number of deaths directly attributable to COVID-19 in Switzerland until April 3, 2022, can be estimated at 18,140 [15,962-20,174] deaths.

• Download figure
• Open in new tab

Figure 1.

(A) Observed and expected number of weekly deaths by age group in Switzerland from February 2020 to April 2022. Model-predicted expected deaths are shown with median and 95% credibility interval. Numbers at the top indicate epidemic phases 1 to 7. (B) Estimated relative excess mortality by seven epidemic phases from February 2020 to April 2022 and five age groups. Medians with 95% credible intervals are shown.

• Download figure
• Open in new tab

Figure 2.

Weekly counts of excess all-cause deaths (95% credibility intervals) and of laboratory-confirmed COVID-19-related deaths between February 24, 2020 and April 3, 2022 in Switzerland by five age groups. Numbers at the top indicate epidemic phases 1 to 7.

After accounting for deaths directly attributable to COVID-19, the observed number of all-cause deaths was slightly lower than expected based on historical trends. This deficit is quantified by β₂, estimated at 0.97 [0.93-1.01], indicating 3% [-1-7] fewer all-cause deaths than expected during the COVID-19 pandemic after adjusting for the direct effect of SARS-CoV-2 infections on mortality. This corresponds to 4,406 [-1,776-10,700] fewer deaths overall compared to expected. The credibility interval is wide, indicating that the data are compatible with no indirect beneficial effect or a slightly harmful indirect effect.

The coefficients β_l and β₂ varied across age groups and time periods. The alignment between excess mortality and laboratory-confirmed deaths was particularly noticeable in age groups 70-79 and 80 and older (Figure 3A and SI Appendix Table S1), and during phases 1, 3 and 6 (SI Appendix, Figure S1). Variation in the relative number of deaths directly attributable to COVID-19 for each laboratory-confirmed death (β_l) by age group suggests that more deaths were not ascertained in age groups 70-79 and 80+, while the data were compatible with 100% ascertainment (β_l = 1) in age groups below 70, where fewer deaths were reported (Figure 3B). β_l was estimated around 1.5 during phases 1 and 3 and around 2 during phase 6, suggesting an ascertainment proportion of COVID-19 deaths during large epidemic waves ranging between 50 and 66% (Figure 3B). This estimate is less precise during periods of low epidemic activity (phases 2, 4, 5 and 7), and remains compatible with 1 (perfect ascertainment). The relative deficit in all-cause deaths (β₂) was more pronounced in age groups 40 to 69 and during phases 1, 3 and 4 (Figure 3C). Estimates of β_l and β₂ across administrative regions show generally homogeneous results for the whole of Switzerland (SI Appendix, Figure S2 and Table S2).

• Download figure
• Open in new tab

Figure 3.

(A) Association between weekly laboratory-confirmed COVID-19-related deaths and absolute excess mortality by age group. The black line shows the slope of association corresponding to a 1 to 1 relation. The red lines show the association estimated with the model (corresponding to the β_l coefficients shown in panel B, the full line represents the point estimate and the dashed lines the lower and upper bounds of the 95% credible interval). (B) Estimates of β_l, the additional number of deaths to be observed for each unit increase in laboratory-confirmed deaths, after adjusting for the expected number of all-causes deaths given historical trends. (C) Estimates of β₂, the additional number of deaths to be observed for each unit increase in the expected number of all-cause deaths, after adjusting for the direct effect of SARS-CoV-2 infections. Estimates of β_l and β₂ are shown for the whole period, by phase and by age group.

Discussion

We examined the patterns of all-cause mortality in Switzerland from the diagnosis of the first COVID-19 case at the end of February 2020 to spring 2022. We compared the excess mortality with laboratory-confirmed COVID-19-related deaths and separated excess mortality into the excess directly attributable to COVID-19 and excess or under mortality indirectly attributable to the pandemic. We found that the estimated number of deaths directly caused by COVID-19 was about 1.4 times higher than the number of laboratory-confirmed deaths. In other words, only about 70% of COVID-19-related deaths were ascertained. Overall, COVID-19 was directly responsible for an estimated 18,000 deaths during the study period, during which only around 13,000 laboratory-confirmed COVID-19-related deaths were reported. Finally, the pandemic may have had an indirect beneficial effect on mortality, estimated at around 4,000 fewer deaths than expected. Of note, this protective effect primarily concerned younger age groups.

Our study has several strengths. Detailed data on the population structure, mortality, weather, and national holidays from the ten years before the COVID-19 pandemic allowed us to estimate what mortality would have been 2020 to 2022 had the pandemic not occurred. Estimation of excess all-cause mortality during the pandemic period by time, space and age thus became possible. Our method has been thoroughly validated (SI Appendix Supporting Information Text) and accounts for the most important determinants of all-cause mortality, including projected population sizes and observed temperature. It correctly handles uncertainty from the different data sources and propagates it to the final estimates. The approach may be used in any setting with reliable reports of all-cause mortality and laboratory-confirmed deaths. Further, we developed a novel statistical method to differentiate between deaths directly attributable to SARS-CoV-2 infections and deaths caused or prevented indirectly by the pandemic. Our study also has several limitations. Information about the cause of death during the study period was not available but would have helped understand the mechanisms of the indirect beneficial effect of the COVID-19 pandemic on mortality. We assumed deaths with a positive SARS-CoV-2 test were caused by COVID-19, although the infection could be incidental in some cases. However, incidental SARS-CoV-2 infections would only concern a small proportion of deaths with laboratory-confirmed infection, equivalent to the prevalence in the general population (41). Autopsies of patients dying in hospital following a positive SARS-CoV-2 test also suggest that during the study period, causes of death were generally directly related to COVID-19 (42). Finally, we did not stratify by sex in this study. In a previous analysis, we found only small differences in excess deaths between sexes (25).

Our estimates of overall excess mortality during the COVID-19 pandemic in Switzerland are consistent with other analyses. The Federal Office of Statistics reported an excess mortality above 10% for January 2020 to August 2021 (29), higher than the 9.7% estimated in the present study for the period up to spring 2022. A multi-country study estimated excess mortality at 13,000 deaths for Switzerland during March 2020 to June 2022 (24, 43) and another one at 15,500 [14,000-17,000] for 2020 and 2021 (28). In our study of five European countries we estimated an excess mortality of 8% in males and 9% in females for Switzerland during the first year of the pandemic (25). WHO estimates for Switzerland 2020 and 2021 were lower (8,200 excess deaths), but there were problems with the WHO estimates (26, 44). None of these studies attempted to quantify the direct and indirect effects of the pandemic on mortality. In line with our estimates, a study in California reported a 78% ascertainment proportion of diagnosed COVID-19 deaths, but did not quantify the indirect effect of the pandemic (45). This is the first study that aims to quantify both the direct and indirect effects of the pandemic on mortality.

We found that COVID-19 caused about 1.4 times more deaths than were laboratory-confirmed, in line with a recent study estimating this ratio at 1.29 [1.16-1.42] for Switzerland (30). Estimates varied widely between countries. For example, the ratio was 0.57 [0-1.25] for Norway but at 150 [140-162] for Nicaragua (30). Differences could be attributable to local healthcare and surveillance systems, testing capacity, and methodological differences in collecting mortality data and estimating excess mortality. We found markedly lower ascertainment during periods of high epidemic activity, suggesting shortcomings in testing, or reporting even in Switzerland, a high-income country. Under-ascertainment was concentrated in older age groups, indicating incomplete ascertainment in retirement and nursing homes, in line with other reports (15). The lower ascertainment towards the end of the study period might be explained by reduced testing once vaccines became available.

We found that in Switzerland, the COVID-19 pandemic probably had an indirect beneficial effect on mortality. A potential explanation is mortality displacement or the “harvesting effect”, where COVID-19 precipitated deaths that would have occurred anyway soon (17-19, 46). However, this is unlikely: the deficit of deaths was concentrated in the younger age groups and not in the over 70 years old, where mortality displacement typically occurs. Therefore, the mortality deficit is probably due to the pandemic’s indirect effects, such as reductions in mobility, road traffic, air pollution and sports activities. The fact that the deficit was more pronounced during phases 1, 3 and 4, when control measures were most stringent (47), supports this interpretation. The concentration of the mortality deficit in the younger age groups also argues against an important role of a reduced prevalence of other pathogens. For example, influenza leads to mortality in the older age groups, the lack thereof would therefore be expected to result in a mortality deficit in these age groups. In any case, we find no evidence for an overall detrimental effect of control measures on mortality. However, we cannot exclude harmful effects such as delays or avoidance of medical care (6, 7), increases in substance use and suicidal ideation (8, 10) or increases in interpersonal violence (11).

Our results are not readily applicable to other countries. Switzerland is a high-income country with a relatively old but healthy population. The stringency of control measures was relatively mild compared to other European countries (48). While any harmful indirect effects of control measures appear to have been more than compensated in Switzerland, further research is required to quantify indirect effects in other countries. Our approach can be used for this purpose, but it does not elucidate the pathways leading to an increase or a decrease in mortality. Further research using cause-specific mortality data is needed to answer this question. Studies over many years are required to gauge the long-term effects on mortality, if any, of the COVID-19 pandemic.

In conclusion, shortcomings in testing coverage caused considerable underestimation of COVID-19-related deaths in Switzerland, particularly in older populations. Although COVID-19 control measures may have negative effects (e.g., delays in medical care or mental health impairments), we note that after subtracting deaths directly caused by SARS-CoV-2 infections, there were fewer deaths in Switzerland during the pandemic than expected. This deficit cannot be attributed to a displacement of mortality, as it was observed mainly in the 40-69 age group. This suggests that any negative effects of control measures on mortality were more than offset by the positive effects. These results have important implications for the ongoing debate about the appropriateness of COVID-19 control measures.

Author Contributions

JR, AH and GK conceived the study. JR and GK drafted the first version of the manuscript, did all statistical analyses, and take responsibility for the integrity of the data and the accuracy of the data analysis. ME revised the manuscript. All authors contributed to the interpretation of data and read and approved the final manuscript.

Competing Interest Statement

We declare no competing interests.

Data sharing

Data on population and all-cause mortality is freely available on the FSO website at https://www.pxweb.bfs.admin.ch/pxweb/en/ and https://www.bfs.admin.ch/bfs/en/home/statistics/population/births-deaths.html. Data on laboratory-confirmed deaths is freely available online (https://www.covid19.admin.ch/en/overview). Daily mean temperature data is freely available online (https://cds.climate.copernicus.eu/cdsapp#!/dataset/reanalysis-era5-single-levels?tab=overview).